In the cohort of training, there was no significant difference in age, sex, tumor location, CA199, AFP, CEA, CT value and enhancement amplitude of each phase between patients with differentiated gastric cancer and patients with undifferentiated gastric cancer. This evidence concerns the gene CEACAM5 and neoplasm.